Literature DB >> 8099049

Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses.

D Otelea1, S Guillot, M Furione, A A Combiescu, J Balanant, A Candrea, R Crainic.   

Abstract

Five type 1 Sabin-like poliovirus strains were isolated from paralytic cases of poliomyelitis. Their Sabin origin was confirmed by antigenic analysis with monoclonal antibodies and restriction fragment length polymorphism (RFLP) assay. Several nucleotide positions known to play a role in the reversion towards neurovirulence were examined: viz 480, 2741, 6203, 7441. Analysis was performed by enzymatic restriction and partial sequencing of PCR-amplified genomic segments. All the strains bore the reversion G > A at residue 480; in four of the five viruses, only this reversion was found. The fifth strain presented four additional reversions and several new mutations. These results indicate that, during multiplication in the human gut, Sabin 1 poliovirus carrying one or several mutations related to reversion towards neurovirulence can be selected.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099049

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  16 in total

1.  Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.

Authors:  V Pliaka; Z Kyriakopoulou; D Tsakogiannis; I G A Ruether; C Gartzonika; S Levidiotou-Stefanou; A Krikelis; P Markoulatos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-05       Impact factor: 3.267

2.  Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.

Authors:  Hiroyuki Shimizu; Bruce Thorley; Fem Julia Paladin; Kerri Anne Brussen; Vicki Stambos; Lilly Yuen; Andi Utama; Yoshio Tano; Minetaro Arita; Hiromu Yoshida; Tetsuo Yoneyama; Agnes Benegas; Sigrun Roesel; Mark Pallansch; Olen Kew; Tatsuo Miyamura
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.

Authors:  M M Georgescu; J Balanant; A Macadam; D Otelea; M Combiescu; A A Combiescu; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Direct detection of Sabin poliovirus vaccine strains in stool specimens of first-dose vaccinees by a sensitive reverse transcription-PCR method.

Authors:  D A Buonagurio; J W Coleman; S A Patibandla; B S Prabhakar; J M Tatem
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

5.  Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Jong-Hoon Kim; Cara C Burns; Olen M Kew; M Steven Oberste; Ousmane M Diop; Steven G F Wassilak; Stephen L Cochi; Kimberly M Thompson
Journal:  Risk Anal       Date:  2013-03-07       Impact factor: 4.000

6.  Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus.

Authors:  A McGoldrick; A J Macadam; G Dunn; A Rowe; J Burlison; P D Minor; J Meredith; D J Evans; J W Almond
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

7.  Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus.

Authors:  M M Georgescu; M Tardy-Panit; S Guillot; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis.

Authors:  M M Georgescu; F Delpeyroux; M Tardy-Panit; J Balanant; M Combiescu; A A Combiescu; S Guillot; R Crainic
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice.

Authors:  M Tardy-Panit; B Blondel; A Martin; F Tekaia; F Horaud; F Delpeyroux
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Growth kinetic analysis of bi-recombinant poliovirus vaccine strains.

Authors:  Vaia Pliaka; Evaggelos Dedepsidis; Zaharoula Kyriakopoulou; Georgia Papadi; Dimitris Tsakogiannis; Anastassia Pratti; Stamatina Levidiotou-Stefanou; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2010-01-21       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.